The hepatitis B vaccine is a critical tool in the prevention of HBV infection. By generating immunity, it reduces the incidence of acute and chronic hepatitis B, thereby decreasing the risk of liver cirrhosis and hepatocellular carcinoma. The widespread use of the vaccine has been instrumental in reducing the prevalence of HBV, especially in countries with high endemic rates.
